Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O7PS
|
|||
| Former ID |
DIB005533
|
|||
| Drug Name |
AERAS-402
|
|||
| Synonyms |
Crucell Ad35; Tuberculosis vaccine (AdVac, PER.C6), Crucell/Aeras; AERAS-402/Crucell Ad35 prime-boost vaccine (tuberculosis), Crucell/Aeras
Click to Show/Hide
|
|||
| Indication | Mycobacterium infection [ICD-11: 1B10-1B21] | Phase 2 | [1] | |
| Company |
Crucell NV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02414828) A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.